Administration of Intravenous Ascorbic Acid—Practical Considerations for Clinicians

Emerging data suggest that intravenous ascorbic acid (AA) may be beneficial in patients with sepsis. Clinicians require data on stability of diluted AA for safe administration. We evaluated the stability of AA diluted in normal saline (NS) or 5% dextrose in water (D5W) solutions over 14 days at 25 °...

Descripción completa

Detalles Bibliográficos
Autores principales: Walker, Scott E., Iazzetta, John, Law, Shirley, Kanji, Salmaan, Bolduc, Brigitte, Lamontagne, François, Adhikari, Neill K.J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769642/
https://www.ncbi.nlm.nih.gov/pubmed/31450771
http://dx.doi.org/10.3390/nu11091994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6769642/
https://www.ncbi.nlm.nih.gov/pubmed/31450771
http://dx.doi.org/10.3390/nu11091994

Ejemplares similares